F. Lorchel

Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial

Eddy Cotte, Guillaume Passot, Évelyne Decullier et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 61 citations

Surgical Oncology, Gastrointestinal Oncology, Good Prognosis +10

Insulin Up-Regulates Vascular Endothelial Growth Factor and Stabilizes Its Messengers in Endometrial Adenocarcinoma Cells¹

Laurent Bermont, Frédérique Lamielle, F. Lorchel et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 42 citations · Full text

Gynecology, Pathology, Insulin Signaling +17

Esophageal cancer: Determination of internal target volume for conformal radiotherapy

F. Lorchel, J.L. Dumas, Alain Noël et al. · Radiotherapy and Oncology · 2006 · 35 citations

Esophagus, Esophageal Cancer, Radiation Therapy +6

Combining Cisplatin and Mitomycin with Radiotherapy in Anal Carcinoma

G. Créhange, M. Bosset, F. Lorchel et al. · Diseases of the Colon & Rectum · 2006 · 32 citations

GANCICLOVIR-SENSITIVE ACUTE GRAFT-VERSUS-HOST DISEASE IN MICE RECEIVING HERPES SIMPLEX VIRUS-THYMIDINE KINASE???EXPRESSING DONOR T CELLS IN A BONE MARROW TRANSPLANTATION SETTING1

Emmanuel Contassot, Christophe Ferrand, R Angonin et al. · Transplantation · 2000 · 29 citations